Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) (“Next Green Wave“, “NGW” or the “Company”) is pleased to confirm the appointment of Norm Mayr to NGW’s Board of Directors.

Norm Mayr is a former audit partner of KPMG in Vancouver, having left the firm in 2016 after 38 years in public practice. In the latter half of his career, he was the Risk Management and Professional Practice Partner for the Greater Vancouver Area practice of KPMG. In this role, Norm was the senior technical partner responsible for consulting with engagement teams dealing with complex financial reporting, accounting, audit and securities matters.


During his career, Norm has had experience in the cannabis, mining, forestry, technology, life sciences, retail and industrial markets sectors. He served as lead engagement partner or quality review partner on many of KPMG’s largest clients in these industries, including several multinational reporting issuers. He has had extensive experience acting for public companies listed in both Canada and the United States.

Norm was a founding member of the CICA Accounting Standards Board from 1991-1994 and a member of the Canadian Advisory Group to the International Accounting Standards Board from 1994-2000. Norm has presented extensively on financial reporting and accounting matters and has been a member and Chair of the Investigation Committee of the Chartered Professional Accountants of British Columbia from 2008 to 2018.

The Company has granted 2,450,000 stock options to its Board of Directors under its stock option plan, exercisable at a price of CDN$0.25 per share, with an expiry date of five years:

  • 850,000 stock options which will vest 25% every 6 months for a period of two years.

  • 1,600,000 stock options which vest 100% on the date of grant.

“Norm’s extensive experience in not only governance, finance and risk management, but also California Cannabis, makes him a perfect addition to guide this company into its next stages. We could not be more excited to have someone of his calibre, and relevant experience, on our team.” – Mike Jennings CEO Next Green Wave

Michael Jennings
Chief Executive Officer, Director
Next Green Wave Holdings Inc.

About Next Green Wave

Next Green Wave is a fully integrated premium seed to shelf craft cannabis producer offering products through its in-house brand portfolio and wholesale flower for other large cannabis manufacturers. The Company owns and operates a 35,000 sf indoor facility in Coalinga, CA which is home to our nursery, cultivation, distribution, and future extraction business. NGW has an exclusive seed library consisting of 120 cannabis strains and hybrids including award-winning cultivars and is producing high quality tissue culture plantlets through its proprietary cloning technology with bio-tech leader Precigen. Marketing, product design and formulation are produced in-house, please follow along us at www.nextgreenwave.com or on Twitter, Instagram, or LinkedIn.

For more information regarding Next Green Wave please contact:

Paul Chow
Director
Tel: +1 (604) 609.6167
IR@nextgreenwave.com

Neither Canadian Securities Exchange (the “CSE”) nor its Regulation Services Providers (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Next Green Wave Forward Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, among others, dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete construction of its proposed facilities in a timely manner; engaging in activities which currently are illegal under US federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; NGW’s limited operating history and lack of historical profits; reliance on management; NGW’s requirements for additional financing, and the effect of capital market conditions and other factors on capital availability, competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although NGW has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. NGW no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/64886

News Provided by Newsfile via QuoteMedia

Anticipates Q1-21 launch for the highly anticipated beverage and distillate vape lines

 Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) (“BevCanna” or the “Company”) is pleased to announce that it has completed its first round of product launch discussions with select provincial buyers throughout Canada . During these in-depth product launch discussions, BevCanna validated its strategy of delivering established U.S. brands to Canadian consumers. Initial provincial feedback has enabled BevCanna to finalize its award-winning lineup of Keef Beverages and Cali -Bloom products, allowing the team to complete the Notice of New Cannabis Product Forms (“NNCP”).

Keep reading... Show less

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Peabody Energy Corporation (NYSE: BTU), Tactile Systems Technology, Inc. (NASDAQ: TCMD), Pintec Technology Holdings Limited (NASDAQ: PT), and Aurora Cannabis, Inc. (NYSE: ACB). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Peabody Energy Corporation (NYSE: BTU)

Keep reading... Show less

 GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) (“GreenStar” or the “Company”) announces it has granted stock options to acquire a total of 1,400,000 common shares of the Company to various directors, officers, and consultants of the Company pursuant to its Stock Option Plan. The options are exercisable at a price of $0.10 per share and expire three years from the date of grant. The options are subject to vesting provisions where 1,000,000 options will vest immediately and 400,000 options will vest 25% per quarter commencing October 31, 2020.

About GreenStar

Keep reading... Show less

 GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) (“GreenStar” or the “Company”) announces it has granted stock options to acquire a total of 1,400,000 common shares of the Company to various directors, officers, and consultants of the Company pursuant to its Stock Option Plan. The options are exercisable at a price of $0.10 per share and expire three years from the date of grant. The options are subject to vesting provisions where 1,000,000 options will vest immediately and 400,000 options will vest 25% per quarter commencing October 31, 2020.

About GreenStar

Keep reading... Show less

Block & Leviton LLP ( www.blockleviton.com ), a national securities litigation firm, reminds investors that securities class actions have been filed against GoHealth, Inc. (NASDAQ: GOCO), NextCure, Inc. (NASDAQ: NXTC), and Aurora Cannabis Inc. (NYSE: ACB). Shareholders interested in serving as lead plaintiff have until the deadlines listed below to move the court. Further details about the cases are described below. There is no cost or obligation to you.

GOCO Shareholders – Click Here: https://www.blockleviton.com/cases/goco

Keep reading... Show less